BMJ  2004;328:907-908 (17 April), doi:10.1136/bmj.328.7445.907

Editorial

Growth hormone: uses and abuses

It has anabolic effects, but its use in ageing and other conditions is not established

The first 150 words of the full text of this article appear below.

The therapeutic use of human growth hormone was first shown 45 years ago.1 In these years the number of approved and proposed uses of human growth hormone has grown from one to more than a dozen, and the number of patients being treated with it has increased from a handful to tens of thousands worldwide. The officially approved uses of human growth hormone vary from country to country, but it is commonly used for children with growth hormone deficiency or insufficiency, poor growth due to renal failure, Turner syndrome (girls with a missing or defective X chromosome), Prader-Willi syndrome (usually due to uniparental disomy in chromosome 15), and children born small for gestational age with poor growth past 2 years of age (table). Recently the Food and Drug Administration in the United States has also approved the use of human growth hormone for short children with idiopathic short . . . [Full text of this article]

Raymond L Hintz, professor of pediatrics

Stanford University, Stanford, CA 94305, USA (hintz@stanford.edu)


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

This article has been cited by other articles:

  • Ahmed, S F, Smith, W A, Blamires, C (2008). Facilitating and understanding the family's choice of injection device for growth hormone therapy by using conjoint analysis. Arch. Dis. Child. 93: 110-114 [Abstract] [Full text]  
  • Gill, D G (2006). "Anything you can do, I can do bigger?": the ethics and equity of growth hormone for small normal children.. Arch. Dis. Child. 91: 270-272 [Abstract] [Full text]  

Rapid Responses:

Read all Rapid Responses

Growth hormone in critically ill patients
Nicola Latronico, et al.
bmj.com, 25 Apr 2004 [Full text]
Short and fat or fat and short?
Matthew P Doogue, et al.
bmj.com, 30 Apr 2004 [Full text]
Growth hormone and systemic enchancement of fracture healing
Eleftherios Tsiridis
bmj.com, 6 May 2004 [Full text]
Growth gormone (GH) therapy may diminish olanzapine serum level
Helmut Niederhofer
bmj.com, 6 Jan 2005 [Full text]



Access all current jobs at BMJ Group
Whats new online at Student 

BMJ
Listen to the latest 

BMJ Interview